Drug Database
CH

chloral hydrate (Escre suppositories)

✓ Approved

Hisamitsu · Small Molecule · Small Molecule

What is chloral hydrate?

chloral hydrate is a small molecule developed by Hisamitsu. It is approved for therapeutic indications via rectal.

Drug Profile

Brand NamesEscre suppositories
CompanyHisamitsu
Drug ClassSmall Molecule
RouteRectal
StatusApproved

Therapeutic Indications

chloral hydrate is developed for 2 unique indications across 2 therapeutic areas.

Therapeutic AreaConditionPhase
Nervous system disordersEpilepsy✓ Approved
Psychiatric disordersInsomnia✓ Approved

Related Research Articles

PubMedTransfusion2026-10-15

Stacking platelet bags: A practical storage configuration for maintaining platelet quality during cold storage.

Mahajan Janhavi J, Lei Pearl P, Roan Christopher C, Padula Matthew P MP et al.

As cold-stored platelets (CSPs) are being integrated into clinical practice, it is necessary to determine the storage practices that best support platelet quality while remaining operationally feasible. Platelet components are traditionally stored at room temperature, in a single layer, to facilitate gas exchange. The reduced metabolic activity of CSPs may allow for the storage of platelet bags in different configurations, offering improved space efficiency in blood bank refrigerators. Matched apheresis platelets (n = 8) in 40% plasma/60% PAS-E (SSP+) were refrigerated (2-6°C) in one of the following storage configurations: single layer (control), stored upright, or stacked flat. In vitro quality parameters were assessed at defined intervals over storage for 22 days. Visible aggregates were identified in 75% of components that were stored upright between days 15 and 22, while no aggregates formed in control or stacked components during the storage period. Platelet components stored upright were more activated at maximal expiry, with greater loss of platelet glycoproteins (GPIbα and GPVI), and an increase in activation markers (P-selectin, annexin-V, and CD61+/annexin-V+ extracellular vesicles). Comparatively, no significant differences in platelet activation markers were observed in stacked platelets at the end of storage compared to controls. No differences in the metabolic or functional capacity of CSPs were observed, regardless of storage configuration. Platelet components stored upright were more activated and prone to aggregate formation over 22 days of storage. In contrast, stacking is a practical storage option that preserves platelet quality while minimizing space requirements in refrigerators and cool rooms.

PubMedCutaneous and ocular toxicology2026-10-14

Huaier cream attenuates TGF-β-induced keloid Fibroblast proliferation and migration by inhibiting the TGF-β/Smad signaling pathway.

Zhao Xuelian X, Gao Yanjun Y, Su Xiaoguang X

To investigate whether Huaier cream (HC) regulates the Transforming growth factor-β/Smad signaling pathway (TGF-β/SSP) and influences the proliferation and migration (P&M), apoptosis, and the synthesis of extracellular matrix (ECM) in keloid fibroblasts (KFs). The KFs model was established in vitro. Live/dead staining (L/D-S) and CCK-8 assays were performed to assess cell proliferation, while the wound healing assay (WHA) was used to evaluate cell migration. Flow cytometry (FC) was taken to assess cell apoptosis. Western blotting (WB) and immunofluorescence (IF) were conducted to determine the changes in TGF-β/SSP and analyze the expression of ECM-related Protein (ECM-RP). HC significantly inhibited the P&M of TGF-β-induced KFs (TGF-β-IKFs), restored their apoptotic capacity, and decreased the expression of ECM-RPs in a concentration-dependent manner. Additionally, HC treatment markedly lowered the Smad2/3's phosphorylation levels, indicating inhibition of the TGF-β/SSP. By suppressing the TGF-β/SSP, HC can inhibit the phosphorylation of TGF-β/SSP and regulate the P&M, apoptosis, and ECM synthesis of TGF-β-IKFs. HC suppresses the TGF-β/SSP, thereby inhibiting the P&M, and ECM synthesis of KFs, while inducing fibroblast apoptosis. These conclusions demonstrate that HC is a potential therapeutic agent for treating keloids.

PubMedBioscience of microbiota, food and health2026-10-14

Therapeutic potential of Sishen Pill: modulating intestinal mucosal microbiota and barrier function in diarrhea-predominant irritable bowel syndrome with Spleen-Kidney Yang Deficiency.

Li Liwen L, Long Qi Q, Tan Zhoujin Z, Deng Na N

This study aimed to investigate the intestinal microecological mechanisms underlying the effects of Sishen Pill (SSP) on diarrhea-predominant irritable bowel syndrome (IBS-D) with Spleen-Kidney Yang Deficiency Syndrome, thereby providing experimental evidence for clinical management. Murine models of IBS-D characterized by Spleen-Kidney Yang deficiency were established in SPF-grade female Kunming mice by Folium senna-adenine gavage in conjunction with restraint-tail clamping. Experimental groups received SSP decoction or pinaverium bromide suspension. Intestinal morphological changes were assessed via Alcian blue staining. The concentrations of serum D-lactate (D-LA) and diamine oxidase (DAO) were measured through enzyme-linked immunosorbent assay. The intestinal mucosal microbiota was analyzed using 16S rRNA gene sequencing. The model mice exhibited reduced anal temperatures, diarrhea, weight loss, intestinal mucosal barrier injury, and altered mucosal microbiota. SSP treatment alleviated these abnormalities, decreased serum D-LA and DAO levels, and improved the intestinal mucosal structure. Microbiota analysis identified Alkaliphilus as a potential genus associated with SSP intervention, while Streptococcus and Maribacter were correlated with intestinal barrier indicators. These findings suggest that SSP may improve IBS-D with Spleen-Kidney Yang Deficiency by modulating the intestinal mucosal microbiota and restoring mucosal barrier function.

PubMedJournal of experimental botany2026-10-14

Zinc finger transcription factor ZAT6 modulates pyroxsulam resistance by activating cytochrome CYP92C6 expression in Italian ryegrass (Lolium perenne ssp. multiflorum).

Yin Shaojing S, Zhang Ming M, Li Jiahao J, Zhou Li L et al.

Herbicide resistance threatens sustainable weed management. Cytochrome P450s (P450s) are well-established core enzymes that mediate metabolic resistance via herbicide detoxification. Nevertheless, the regulatory mechanisms of P450 overexpression in resistant weeds remain largely uncharacterized. Here, we aimed to characterize the functions of P450 genes in pyroxsulam-resistant Italian ryegrass (Lolium perenne ssp. multiflorum) and elucidate their transcriptional regulatory mechanisms. CYP92C6 was identified as a pivotal gene contributing to metabolic resistance in L. perenne ssp. multiflorum. Overexpression of CYP92C6 in Arabidopsis thaliana or rice significantly enhanced tolerances to pyroxsulam. Combined analysis of transcriptomic data and dual-luciferase reporter assays demonstrated the zinc finger transcription factor ZAT6 acts as a direct upstream regulator of CYP92C6, and ZAT6 specifically binds to the promoter region of CYP92C6. The critical cis-acting element responsible for ZAT6 binding within the CYP92C6 promoter was also defined. Overexpression of ZAT6 in Arabidopsis enhanced herbicide resistance, and nuclear localization of ZAT6 was indispensable for its regulatory activity. Collectively, we conclude that ZAT6 directly activates the expression of CYP92C6 to facilitate pyroxsulam detoxification, thereby conferring pyroxsulam resistance in L. perenne ssp. multiflorum. These findings deepen our mechanistic understanding of the transcriptional regulation underlying metabolic resistance to pyroxsulam in L. perenne ssp. multiflorum.

PubMedTropical doctor2026-10-14

The surgical sustainability phenotype (SSP): A proposed framework for environmental phenotyping in surgery.

Sharma Dhananjaya D, Cotton Michael M

PubMedEnvironmental research2026-10-14

Hemihydrate phosphogypsum as a waste-derived sulfate source for low-carbon supersulfated cement: Hydration regulation and strength-normalized environmental performance.

Sun Zhengning Z, Wang Boxin B, Zuo Yibing Y, Mu Ru R et al.

Hemihydrate phosphogypsum (HPG) can serve as a waste-derived sulfate source in low-clinker supersulfated cement (SSC), expanding phosphogypsum utilization while reducing demand for natural gypsum. This study examines how HPG content governs the temporal evolution of sulfate supply and how this evolution relates to hydration, pore structure, and long-term strength in SSC co-activated with ferroaluminate clinker (FAC), carbide slag (CS), and sodium silicate (SS). Mixtures containing 5-25 wt% HPG were evaluated for compressive strength. The 10, 15, and 20 wt% HPG mixtures were further analyzed by hydration kinetics, pore-solution chemistry, quantitative phase analysis, and microstructural characterization. Composite-activated SSC developed 10.23-14.36 MPa at 1 d, corresponding to a 205.4-328.7% increase over the CS-activated reference. The 15 and 20 wt% HPG mixtures reached 65.54 and 63.76 MPa at 28 d and continued to increase to 81.56 and 78.79 MPa at 270 d, respectively. At 10 wt% HPG, sulfate depletion after early hydration constrained continued ettringite formation and late-age pore refinement. At 20 wt% HPG, sustained reaction of ground granulated blast-furnace slag (GGBS) generated slightly more ettringite and C-(A)-S-H, but a larger fraction of pores >50 nm remained, diminishing the strength efficiency of the additional hydration products. The 15 wt% HPG mixture provided the most favorable coupling of sulfate supply, hydrate accumulation, pore refinement, and strength, and achieved the lowest 28 d energy- and carbon-intensity indices among the investigated mixtures.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about chloral hydrate